VR Logo

Radius Health Inc. (RDUS) download report


Healthcare | Drugs & Pharma

Radius Health Inc. (RDUS) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology.

IPO Date: 06-Jun-2014

CEO, Pres & Director: Mr. G. Kelly Martin

VP of Sales & Head of U.S. Sales Channels: Ms. Danielle Holtschlag

Listing: NASDAQ: RDUS

Country: United States

Headquarters: Boston, MA

Website: https://radiuspharm.com

Key Facts

Market cap: $498.85 Mln

Revenue (TTM): $216.87 Mln

Earnings (TTM): $-72.70 Mln

Cash: $71.62 Mln

Total Debt: $340.14 Mln

Insider's Holding: 0.53%

Liquidity: Low

52 Week range: $4.97 - 23.00

Shares outstanding: 47,600,500

10 Years Aggregate:

  • CFO: $-953.63 Mln
  • EBITDA: $-1,152.36 Mln
  • Net Profit: $-1,264.58 Mln

Stock Performance

Time Period Radius Health (RDUS) S&P BSE Healthcare* S&P Small-Cap 600*
YTD52.02-16.34-18.67
1 month60.86-0.55-8.32
3 months17.41-11.78-14.04
1 Year-41.06-15.85-16.76
3 Years-25.0619.906.23
5 Years-25.549.045.72
10 Years--12.199.63
As on 05-Jul-2022 *As on 06-Jul-2022
Year Radius Health (RDUS) S&P Small-Cap 600 S&P BSE Healthcare
2021-61.2525.2720.87
2020-11.419.5761.45
201922.2620.86-3.55
2018-47.91-9.70-5.89
2017-16.4611.730.49
2016-38.2024.74-12.88
201558.16-3.3615.06